{"abstract":"The Surgery Branch (SB) at the National Cancer Institute (NCI), is seeking a partner in the private sector to provide Good Manufacturing Practice-grade vaccine directed against cancer neo- antigens with the goal of conducting a Phase-I human clinical trial for solid cancers.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/08/02/2024-17129.html","cfr_references":[],"citation":"89 FR 63209","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":null,"disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2024-17129","effective_on":null,"end_page":63210,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/08/02/2024-17129.xml","html_url":"https://www.federalregister.gov/documents/2024/08/02/2024-17129/collaboration-opportunity-for-combination-of-vaccine-with-adoptive-cell-therapies-made-at-nci-for","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-17129?publication_date=2024-08-02","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-08-02/2024-17129/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":54,"last_updated":"2026-04-04 20:15:04 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-08-02/pdf/2024-17129.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-17129.pdf?1722516341","publication_date":"2024-08-02","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/08/02/2024-17129.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2024-08-02T08:08:29Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":63209,"subtype":null,"title":"Collaboration Opportunity for Combination of Vaccine With Adoptive Cell Therapies Made at NCI for the Treatment of Solid Cancers","toc_doc":"Combination of Vaccine with Adoptive Cell Therapies made at the National Cancer Institute for the Treatment of Solid Cancers","toc_subject":"Collaboration Opportunity:\n","topics":[],"type":"Notice","volume":89}